KRAS and lung cancer: We have further described that WSE related lung cancer is associated with an older age at diagnosis, adenocarcinoma histology, pleural effusion, high prevalence of EGFR mutations (55.4 %) and a low prevalence of KRAS mutation (6 %), compared to patients with smoking history [15].